View Older Stories View More Recent Stories
-
Lazard Capital Initiates Coverage on Independent Oil & Gas Stocks - CHK, KWK, RRC & WLL
-
Lazard Capital Downgrades Abiomed (ABMD) to Hold
-
Solar IPO for STR Holdings (STRI) Opens Higher After Pricing Lower
-
Lazard Capital Maintains a 'Buy' on Visa (V); Raises PT to $86 After Meeting With Management
-
Lazard Downgrades AEO, WRC, ELY, JNY, ZQK, TRLG to Hold, SKS to Sell
-
Notable Analyst Rating Changes: CSX, UNH, DF, TS Upgraded; SNDK, INTC, VALE Upgraded
-
MasterCard (MA) Q3 Profits See a Charge, But Shares Down (Update)
-
Lazard Capital Initiates Coverage on A123 Systems (AONE) with a Buy
-
Barclays & Lazard Capital Upgrade Human Genome Sciences (HGSI)
-
Lazard Capital Downgrades MAKO Surgical (MAKO) to Hold
-
Trading Radar for 10/28: First Solar (FSLR), ConocoPhillips (COP), WellPoint (WLP), Goodyear (GT), Int. Paper (IP) Report
-
Lazard Ltd (LAZ) Posts Q3 EPS of $0.41, Beats By 4c
-
Lazard (LAZ) Declared a $0.125 Quarterly Dividend; 1.3% Yield
-
Intuitive Surgical (ISRG) Readies To Slice Up Q3 Estimates
-
Lazard (LAZ) Issues Statement on Chairman and CEO Succession
-
Mead Johnson (MJN) November volatility at 44 into EPS
-
Top 10 News Items 10/12-10/16: Dow Crosses 10,000; Google Blows-Out Earnings; Goldman Continues Earnings Dominance, But Traders Sell
-
Lazard Capital Initiates Coverage on Laboratory Corp of America (LH) with a Hold
-
Lazard Capital Initiates Coverage on Quest Diagnostics (DGX) with a Hold
-
Lazard Capital Upgrades Progenics Pharmaceuticals (PGNX) to Buy
-
Lazard Capital Upgrades Progenics Pharmaceutical (PGNX) to Buy
-
Savient Pharma (SVNT) Closes 4.95M Share Public Offering
-
Notable Analyst Rating Changes 10/15: JPM, PCG, NVLS, PRX Upgrade; BJS, BHI, SCHW, AZ, TRV, LAZ Downgrade
-
Daily State of the Markets: Here We Go Again
-
Oppenheimer Downgrades Lazard Ltd (LAZ) to Perform
-
Lazard Capital Markets Starts CYH at Buy; HMA, LPNT, THC, UHS at Hold
-
Collins Stewart Sees Sell-Off in Lazard (LAZ) Following Wasserstein News; Buy on Any Weakness
-
Lazard's (LAZ) Bruce Wasserstein Dies
-
Hearing reports Lazard (LAZ) CEO Bruce Wasserstein has died. Note LAZ is halted
-
Lazard Ltd. (LAZ) Halted; News pending
-
Bove Sees JPMorgan (JPM) at $90 'Two to Three Years Out'
-
DryShips (DRYS) Shares Rising as Lazard Gets Bullish
-
Lazard Capital Market Lifts Price Target Deckers Outdoor (DECK) to $115
-
Notable Analyst Rating Changes 10/13: PKX, DRYS, YHOO, AMD, PHG Upgrade; GS, VPRT, SVU, GAP, SWY, DRIV Downgrade
-
Morning Movers 10/13: TCHC, STAR, CGEN, RAMS, PIR, VASC Higher; CIT, TLVT, GAP, PPO, INTT, DPZ Lower
-
Daily State of the Markets Wait For It…
-
Traders Cheer Lazard's Upgrade on DryShips (DRYS)
-
Goldman Sachs Sees a "Perfect Storm" for M&A
-
Lazard Capital Downgrades Digital River (DRIV) to Hold
-
Lazard's (LAZ) Wasserstein Hospitalized
-
Lazard Ltd (LAZ) Names Jeffrey H. Cohen as Global Head of Retail
-
Notable Analyst Rating Changes 10/8: RAX, CLX, EBAY, GME, MWW, AUY Upgrade; TTM, LLL, PLCM Downgrade
-
Lazard Starts King Pharma (KG) at Buy
-
Lazard Capital Initiates Coverage on Business/Electronic Banking Services Stocks
-
Unusual 11 Mid-Day Movers 10/05: ROIAK, DEPO, AVII, CMLS Higher; FOLD, SGEN, SCLN, REED Lower
-
Lazard Capital Upgrades Symantec (SYMC) to Buy
-
Lazard Capital Downgrades Amicus Therapeutics (FOLD) to Hold
-
Notable Analyst Rating Changes 9/30: NKE, HBAN, AMSC, CPSL, EHTH, ADM Upgraded; TGT, PSSI, GLBC, ICON Downgraded
-
Intel (INTC) volatility flat at 36 into EPS
-
Lazard Starts Intel (INTC) at Buy

